ANTIVIRAL COMPOUNDS AND COMPOSITIONS THEREFROM

The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. It also relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof for use in medicine, in particular for the prevention of treatment of infection by coronavirus. The inv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GASTAMINZA LANDART, Pablo, HERRANZ HERRANZ, Rosario, CABRERA TORREJÓN, Daniel, BUENO FERNÁNDEZ, Paula, GUTIÉRREZ RODRÍGUEZ, Marta, CASTRO NAVAS, Francisco F, CASTRO ILLANA, Victoria, GARAIGORTA DE DIOS, Urtzi
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GASTAMINZA LANDART, Pablo
HERRANZ HERRANZ, Rosario
CABRERA TORREJÓN, Daniel
BUENO FERNÁNDEZ, Paula
GUTIÉRREZ RODRÍGUEZ, Marta
CASTRO NAVAS, Francisco F
CASTRO ILLANA, Victoria
GARAIGORTA DE DIOS, Urtzi
description The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. It also relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof for use in medicine, in particular for the prevention of treatment of infection by coronavirus. The invention also relates to a process for the preparation of a compound of formula (I) or a pharmaceutically acceptable salt thereof formula (I). La présente divulgation concerne un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci destiné à être utilisé en médecine, en particulier pour la prévention du traitement d'une infection par le coronavirus. L'invention concerne également un procédé de préparation d'un composé de formule (I) ou d'un sel pharmaceutiquement acceptable de celui-ci, formule (I).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023217539A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023217539A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023217539A13</originalsourceid><addsrcrecordid>eNrjZNBz9AvxDPMMcvRRcPb3DfAP9XMJVnD0c4Hwgj1DPP39ghVCPFyDXN2C_H15GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgZGxkaG5qbGlo6ExcaoApiQnEQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIVIRAL COMPOUNDS AND COMPOSITIONS THEREFROM</title><source>esp@cenet</source><creator>GASTAMINZA LANDART, Pablo ; HERRANZ HERRANZ, Rosario ; CABRERA TORREJÓN, Daniel ; BUENO FERNÁNDEZ, Paula ; GUTIÉRREZ RODRÍGUEZ, Marta ; CASTRO NAVAS, Francisco F ; CASTRO ILLANA, Victoria ; GARAIGORTA DE DIOS, Urtzi</creator><creatorcontrib>GASTAMINZA LANDART, Pablo ; HERRANZ HERRANZ, Rosario ; CABRERA TORREJÓN, Daniel ; BUENO FERNÁNDEZ, Paula ; GUTIÉRREZ RODRÍGUEZ, Marta ; CASTRO NAVAS, Francisco F ; CASTRO ILLANA, Victoria ; GARAIGORTA DE DIOS, Urtzi</creatorcontrib><description>The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. It also relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof for use in medicine, in particular for the prevention of treatment of infection by coronavirus. The invention also relates to a process for the preparation of a compound of formula (I) or a pharmaceutically acceptable salt thereof formula (I). La présente divulgation concerne un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci destiné à être utilisé en médecine, en particulier pour la prévention du traitement d'une infection par le coronavirus. L'invention concerne également un procédé de préparation d'un composé de formule (I) ou d'un sel pharmaceutiquement acceptable de celui-ci, formule (I).</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231116&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023217539A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231116&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023217539A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GASTAMINZA LANDART, Pablo</creatorcontrib><creatorcontrib>HERRANZ HERRANZ, Rosario</creatorcontrib><creatorcontrib>CABRERA TORREJÓN, Daniel</creatorcontrib><creatorcontrib>BUENO FERNÁNDEZ, Paula</creatorcontrib><creatorcontrib>GUTIÉRREZ RODRÍGUEZ, Marta</creatorcontrib><creatorcontrib>CASTRO NAVAS, Francisco F</creatorcontrib><creatorcontrib>CASTRO ILLANA, Victoria</creatorcontrib><creatorcontrib>GARAIGORTA DE DIOS, Urtzi</creatorcontrib><title>ANTIVIRAL COMPOUNDS AND COMPOSITIONS THEREFROM</title><description>The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. It also relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof for use in medicine, in particular for the prevention of treatment of infection by coronavirus. The invention also relates to a process for the preparation of a compound of formula (I) or a pharmaceutically acceptable salt thereof formula (I). La présente divulgation concerne un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci destiné à être utilisé en médecine, en particulier pour la prévention du traitement d'une infection par le coronavirus. L'invention concerne également un procédé de préparation d'un composé de formule (I) ou d'un sel pharmaceutiquement acceptable de celui-ci, formule (I).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBz9AvxDPMMcvRRcPb3DfAP9XMJVnD0c4Hwgj1DPP39ghVCPFyDXN2C_H15GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgZGxkaG5qbGlo6ExcaoApiQnEQ</recordid><startdate>20231116</startdate><enddate>20231116</enddate><creator>GASTAMINZA LANDART, Pablo</creator><creator>HERRANZ HERRANZ, Rosario</creator><creator>CABRERA TORREJÓN, Daniel</creator><creator>BUENO FERNÁNDEZ, Paula</creator><creator>GUTIÉRREZ RODRÍGUEZ, Marta</creator><creator>CASTRO NAVAS, Francisco F</creator><creator>CASTRO ILLANA, Victoria</creator><creator>GARAIGORTA DE DIOS, Urtzi</creator><scope>EVB</scope></search><sort><creationdate>20231116</creationdate><title>ANTIVIRAL COMPOUNDS AND COMPOSITIONS THEREFROM</title><author>GASTAMINZA LANDART, Pablo ; HERRANZ HERRANZ, Rosario ; CABRERA TORREJÓN, Daniel ; BUENO FERNÁNDEZ, Paula ; GUTIÉRREZ RODRÍGUEZ, Marta ; CASTRO NAVAS, Francisco F ; CASTRO ILLANA, Victoria ; GARAIGORTA DE DIOS, Urtzi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023217539A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GASTAMINZA LANDART, Pablo</creatorcontrib><creatorcontrib>HERRANZ HERRANZ, Rosario</creatorcontrib><creatorcontrib>CABRERA TORREJÓN, Daniel</creatorcontrib><creatorcontrib>BUENO FERNÁNDEZ, Paula</creatorcontrib><creatorcontrib>GUTIÉRREZ RODRÍGUEZ, Marta</creatorcontrib><creatorcontrib>CASTRO NAVAS, Francisco F</creatorcontrib><creatorcontrib>CASTRO ILLANA, Victoria</creatorcontrib><creatorcontrib>GARAIGORTA DE DIOS, Urtzi</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GASTAMINZA LANDART, Pablo</au><au>HERRANZ HERRANZ, Rosario</au><au>CABRERA TORREJÓN, Daniel</au><au>BUENO FERNÁNDEZ, Paula</au><au>GUTIÉRREZ RODRÍGUEZ, Marta</au><au>CASTRO NAVAS, Francisco F</au><au>CASTRO ILLANA, Victoria</au><au>GARAIGORTA DE DIOS, Urtzi</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIVIRAL COMPOUNDS AND COMPOSITIONS THEREFROM</title><date>2023-11-16</date><risdate>2023</risdate><abstract>The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. It also relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof for use in medicine, in particular for the prevention of treatment of infection by coronavirus. The invention also relates to a process for the preparation of a compound of formula (I) or a pharmaceutically acceptable salt thereof formula (I). La présente divulgation concerne un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci destiné à être utilisé en médecine, en particulier pour la prévention du traitement d'une infection par le coronavirus. L'invention concerne également un procédé de préparation d'un composé de formule (I) ou d'un sel pharmaceutiquement acceptable de celui-ci, formule (I).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2023217539A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ANTIVIRAL COMPOUNDS AND COMPOSITIONS THEREFROM
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T19%3A21%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GASTAMINZA%20LANDART,%20Pablo&rft.date=2023-11-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023217539A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true